Collegium Pharmaceutical(COLL) - 2023 Q1 - Quarterly Report

On February 25, 2022, in connection with the BDSI Acquisition, a purported individual stockholder of BDSI filed a complaint in the United States District Court for the Southern District of New York, captioned Stein v. BioDelivery Sciences International, Inc., et al., No. 1:22-cv-01600, naming as defendants BDSI and each member of its Board of Directors as of the date of the Merger Agreement ("Stein Action"). On February 28, 2022, two additional cases were filed by purported individual stockholders of BDSI i ...